Search
  1. Home
  2. Southern Africa
  3. South Africa
  • News

AIDS drug recalled following safety concerns

    JOHANNESBURG

    South Africa's Medicines Control Council (MCC) on Thursday used its powers to enforce a recall of all stocks of the generic anti-AIDS drug, Duovir.

    The medication is manufactured by India's Cipla-Medpro, and is a single-dose combination of the patented medicines, Zidovudine and Lamivudine.

    According to a press statement by the AIDS lobby group, Treatment Action Campaign, the MCC declared the antiretroviral "undesirable" after concerns were raised about the quality of the bioequivalence studies that formed the basis of its registration.

    HIV-positive people using the drug have been advised to consult their doctors for equivalent or alternative treatment.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join